Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.3.0.814
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Statement of Cash Flows [Abstract]    
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 5,385 $ 4,204
INVESTING ACTIVITIES    
Acquisition of business (5,899)  
Purchase of medical equipment and property (9,390) (7,168)
Proceeds from sale of medical equipment and property 2,599 5,193
NET CASH USED IN INVESTING ACTIVITIES (12,690) (1,975)
FINANCING ACTIVITIES    
Principal payments on revolving credit facility, term loans and capital lease obligations (52,681) (49,101)
Cash proceeds from revolving credit facility 60,605 47,814
Debt issuance costs (157)  
Common stock repurchased to satisfy statutory withholding on employee stock based compensation plans (144) (178)
Cash proceeds from stock plans 156  
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 7,779 (1,465)
Net change in cash and cash equivalents 474 764
Cash and cash equivalents, beginning of period 515 1,138
Cash and cash equivalents, end of period $ 989 $ 1,902